Xeris Pharmaceuticals Presents Non-Aqueous Glucagon Stability Data at the American Diabetes Association 73nd Scientific Sessions
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Austin, TX, June 21, 2013 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris") announces today that it is presenting at the American Diabetes Association 73nd Scientific Sessions in Chicago, IL from June 21 to 25. Steve Prestrelski, Ph.D. and Chief Executive Officer, will present on Xeris' soluble glucagon formulation based on biocompatible, non-aqueous solutions.
Help employers find you! Check out all the jobs and post your resume.
Austin, TX, June 21, 2013 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris") announces today that it is presenting at the American Diabetes Association 73nd Scientific Sessions in Chicago, IL from June 21 to 25. Steve Prestrelski, Ph.D. and Chief Executive Officer, will present on Xeris' soluble glucagon formulation based on biocompatible, non-aqueous solutions.
Help employers find you! Check out all the jobs and post your resume.